Publication | Open Access

Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman Primates

NanomedicineHiv DrugsMedicineImmunologyDrug-combination Nanoparticles ExhibitAntiviral ResponseVirologyAntiviral Drug DevelopmentAntiviral TherapyAntiviral DrugHivNonhuman PrimatesPharmacologyAntiviral Compound